Want to see CLPT full AI Analyst Report?
CLPT Stock Chart & Stats
$14.12
-$0.37(-2.55%)
At close: 4:00 PM EDT
$14.12
-$0.37(-2.55%)
Day’s Range― - ―
52-Week Range$8.27 - $30.10
Previous CloseN/A
Volume467.36K
Average Volume (3M)846.78K
Market Cap
$448.04M
Enterprise Value$572.76
Total Cash (Recent Filing)$29.36M
Total Debt (Recent Filing)$63.95M
Price to Earnings (P/E)―
Beta1.89
Next Earnings
Nov 05, 2026EPS Estimate
-0.32Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.18
Shares Outstanding29,989,563
10 Day Avg. Volume526,333
30 Day Avg. Volume846,785
Financial Highlights & Ratios
PEG Ratio-0.53
Price to Book (P/B)13.82
Price to Sales (P/S)10.48
P/FCF Ratio-15.84
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$25.67Price Target Upside81.78% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-1.11
Revenue Forecast (FY)$53.13M
Bulls Say, Bears Say
Bulls Say
Balance SheetThe balance sheet is solid with over $20M of cash and no debt.
EarningsFunctional Neuro growth was strong at 43% year-over-year.
Partnership DevelopmentsThe partner business recently had significant developments that accelerate $100s of millions of revenue opportunities, with 70%+ gross margins.
Bears Say
Market Entry TimingRevenue opportunities from the partner business are expected to be on the market as early as late 2026.
CLPT FAQ
What was Clearpoint Neuro, Inc.’s price range in the past 12 months?
Clearpoint Neuro, Inc. lowest stock price was $8.27 and its highest was $30.10 in the past 12 months.
What is Clearpoint Neuro, Inc.’s market cap?
Clearpoint Neuro, Inc.’s market cap is $448.04M.
When is Clearpoint Neuro, Inc.’s upcoming earnings report date?
Clearpoint Neuro, Inc.’s upcoming earnings report date is Nov 05, 2026 which is in 91 days.
How were Clearpoint Neuro, Inc.’s earnings last quarter?
Clearpoint Neuro, Inc. released its earnings results on Aug 03, 2026. The company reported -$0.38 earnings per share for the quarter, missing the consensus estimate of -$0.287 by -$0.093.
Is Clearpoint Neuro, Inc. overvalued?
According to Wall Street analysts Clearpoint Neuro, Inc.’s price is currently Undervalued.
Does Clearpoint Neuro, Inc. pay dividends?
Clearpoint Neuro, Inc. does not currently pay dividends.
What is Clearpoint Neuro, Inc.’s EPS estimate?
Clearpoint Neuro, Inc.’s EPS estimate is -0.32.
How many shares outstanding does Clearpoint Neuro, Inc. have?
Clearpoint Neuro, Inc. has 29,989,563 shares outstanding.
What happened to Clearpoint Neuro, Inc.’s price movement after its last earnings report?
Clearpoint Neuro, Inc. reported an EPS of -$0.38 in its last earnings report, missing expectations of -$0.287. Following the earnings report the stock price went down -16.287%.
Which hedge fund is a major shareholder of Clearpoint Neuro, Inc.?
Currently, no hedge funds are holding shares in CLPT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
ClearPoint Neuro Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$25.67 (81.78% Upside)
$25.67 (81.78% Upside)
Blogger Sentiment
Neutral
CLPT Sentiment 60%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 21.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $251.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 2.4%
Last 30 Days ▼ 0.4%
Last 30 Days ▼ 0.4%
News Sentiment
Bullish
Bullish news 75%
Bearish news 25%
Bearish news 25%
Technicals
SMA
Positive
20 days / 200 days
Momentum
30.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
210.66%
Trailing 12-Months
Company Description
Clearpoint Neuro, Inc.
ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.
CLPT Company Deck
CLPT Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a largely constructive strategic and operational picture: top‑line growth (18% YoY), improved gross margin, successful product adoption (notably IRRAflow and updated navigation software), acquisition of the CAL facility with a signed GLP statement of work, and encouraging partner regulatory momentum. These positives are tempered by meaningful near‑term challenges — a sizable cash decline driven by a $15M operational burn through Q2, substantial increases in operating expenses, a 15% decline in biologics & drug delivery revenue in the quarter, and delayed GLP/preclinical revenue recognition into 2027. Management framed the expense increases as purposeful investments to capture accelerated partner launches and long‑term opportunity. On balance, the strategic catalysts and partner momentum appear to outweigh the near‑term financial pressures, though execution on timing and cash management will be critical.View all CLPT earnings summariesCLPT Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$25.67
▲(81.78% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Ownership Overview
3.84% Insiders
8.86% Mutual Funds
2.59% Other Institutional Investors
74.86% Public Companies and
Individual Investors











